North America Throat Cancer Diagnostics Market
市场规模（十亿美元）
CAGR :
% 
USD
716.67 Million
USD
1,305.24 Million
2022
2030
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 716.67 Million |
 Market Size (Forecast Year) |
USD 1,305.24 Million |
 CAGR |
% |
| Major Markets Players |
|
北美喉癌诊断市场，按产品类型（仪器和消耗品及配件）、测试类型（影像测试、血液测试、活检等）、癌症类型（咽癌和喉癌）、分期（0 期、I 期、II 期、III 期和 IV 期）、年龄组（30-65 岁、65 岁及以上、21-29 岁和 21 岁以下）、最终用户（医院、相关实验室、独立诊断实验室、诊断影像中心、癌症研究机构等）、分销渠道（直接招标和零售销售）划分 - 行业趋势和预测到 2030 年。
北美喉癌诊断市场分析与洞察
人们对喉癌的认识不断提高，增强了市场需求。为获得更好的医疗服务而增加的医疗支出也促进了市场的增长。在这一关键时期，主要的市场参与者专注于各种服务的推出和批准。
北美喉癌诊断市场预计将在 2023 年至 2030 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，该市场将以 7.8% 的复合年增长率增长，预计到 2030 年将从 2022 年的 7.1667 亿美元达到 13.0524 亿美元。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制至 2020-2015) |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
按产品类型（仪器和耗材及配件）、测试类型（影像测试、血液测试、活检等）、癌症类型（咽癌和喉癌）、分期（0 期、I 期、II 期、III 期和 IV 期）、年龄组（30-65 岁、65 岁及以上、21-29 岁和 21 岁以下）、最终用户（医院、相关实验室、独立诊断实验室、诊断影像中心、癌症研究机构等）、分销渠道（直接招标和零售） |
|
覆盖国家 |
美国、加拿大、墨西哥 |
|
涵盖的市场参与者 |
F. Hoffmann-La Roche Ltd.、富士胶片株式会社、赛默飞世尔科技公司、佳能医疗系统公司、荷兰皇家飞利浦公司、默克集团、BD、通用电气公司、Illumina、安捷伦科技公司、Bio-Rad Laboratories, Inc.、雅培、QIAGEN、西门子医疗有限公司、Myriad Genetics Inc.、Quest Diagnostics Incorporated、Hologic、FONAR Corp.、Time Medical Holding.、MinFound Medical Systems Co., Ltd 和 PlexBio 等 |
市场定义
喉癌是发生在咽喉（颈部中空的管道，始于鼻后，止于气管和食道顶端）组织中的一种癌症。喉癌包括鼻咽（鼻后咽喉上部）、口咽（咽喉中部）和下咽（咽喉下部）的癌症。喉癌也可能包括喉癌。大多数喉癌是鳞状细胞癌（始于薄而扁平的细胞，看起来像鱼鳞），也称为咽癌。
北美喉癌诊断市场动态
驱动程序
- 喉癌发病率不断上升
喉癌是成人和儿童中诊断出的第二大常见白血病，但大多数病例发生在成人身上。虽然喉癌可以在任何年龄诊断，但在 45 岁之前并不常见。平均诊断年龄为 68 岁。香烟和其他烟草替代品的使用增加可能是喉癌患病率上升的部分原因。
患有喉癌的人会出现咳嗽、声音变化（如声音嘶哑或说话不清楚）、吞咽困难、耳痛、肿块或疮无法愈合、喉咙痛、体重减轻等症状。
- 喉癌诊断的新技术进步
放射治疗在喉癌治疗中起着不可或缺的作用。尽管放射治疗有可能治愈晚期患者，但也有可能带来严重的长期发病率。头颈部放射治疗方面的新技术正在涌现，有可能提高治愈率并降低毒性。这些新技术包括改进的放射治疗设计（调强放射治疗）和改进的计划和实施（图像引导放射治疗）。
限制
- 喉癌诊断较晚、预后不良
癌症是全球死亡的主要原因。到 2030 年，预计每年将有 1310 万人死于癌症。但是，如果及早发现并给予正确的治疗，一些癌症是可以治愈的。诊断过程可能会延迟癌症诊断。当患者忽视或未能对潜在的癌症迹象做出反应时，患者诊断过晚会导致癌组织生长，使癌症病情恶化。延迟就诊的主要原因是公众缺乏对早期癌症迹象的了解，尤其是当这些症状不寻常时。
因此，这些因素往往会导致诊断延迟，从而导致预后不良。因此，这些因素预计将抑制北美喉癌诊断市场的增长。
诊断设备安装成本高
由于喉癌患者数量不断增加，医疗设备价格不断上涨，癌症诊断费用也变得越来越昂贵。用于癌症诊断的现代技术设备也在癌症诊断的高价格中发挥着重要作用，为甲状腺结节中的癌症提供了高精度的明确诊断。因此，喉癌诊断程序的高成本阻碍了市场的增长。
用于检测癌症的诊断产品或设备正在变得越来越先进。然而，癌症诊断程序也非常昂贵，这阻碍了喉癌诊断市场的增长，因为用于癌症诊断过程中的设备对于癌组织的早期检测越来越昂贵，这导致诊断程序的成本增加。
机会
- 癌症诊断和治疗的医疗支出增加
在全球范围内，由于公共卫生支出与经济表现的增加，研发活动正在不断升级。不断增加的医疗支出可能会带来更好的研发机会。预计这将增加对咽喉诊断的需求。增加癌症治疗的医疗支出也有助于患者轻松获得先进的诊断和治疗，从而快速康复。医疗保健支出由自付费用（人们支付医疗费用）、政府支出和各种来源（例如不同地区政府发布的不同医疗保健计划）组成。它还包括健康保险和非政府组织的活动。癌症治疗医疗支出的增加是市场需求的机会。
- 政府针对癌症诊断的举措
政府在应对癌症方面发挥着重要作用，因为癌症是全球主要疾病。过去几十年来，喉癌在个人中增长非常迅速。根据 cancer.gov 的数据，喉癌是最常见的癌症，2022 年估计有 410,376 人新增病例。
政府采取了多项举措，帮助刺激市场需求，这些举措将提高人们对健康的认识，并尽早诊断，以便更好地治疗和预防。不断增长的医疗支出也有利于进一步的经济增长和医疗保健行业的增长，而且它主要是富有成效的，因为它显著影响了各种诊断产品的更好和更先进的治疗方案的开发。
挑战
- 成本增加、安全和便利问题
喉癌是致命的，这种癌症的诊断过程也存在安全问题。而且它也不划算。癌症是全球治疗成本最高的疾病之一。癌症患者可能住院并接受各种治疗，如手术、放射治疗和全身治疗。癌症患者的健康保险费现在比过去更贵。此外，他们的自付额、免赔额和共同保险费用也在上升。
预计，氦气短缺和过度辐射风险的增加将限制 CT 扫描仪的使用，威胁到资本投资增加和生物标志物效益成本比降低的可能性。发展中国家的许多医院无法投资诊断成像设备，这导致重建诊断成像的使用因高支出和财务限制而增加。
最新动态
- 2022 年 8 月，罗氏公司宣布推出数字 LightCycler 系统，这是罗氏的首款数字聚合酶链反应 (PCR) 系统。这款新一代系统可检测疾病，旨在准确量化传统 PCR 方法通常无法检测到的特定 DNA 和 RNA 靶标的微量。这有助于该公司扩大其在北美市场的影响力
- 2021 年 3 月，Hologic 公司宣布收购 Diagenode，后者是一家私营 Globalan 公司，主要开发和生产分子诊断检测和表观遗传学产品。这进一步加强了其在北美市场的分子诊断业务
北美喉癌诊断市场范围
北美喉癌诊断市场细分为产品类型、检测类型、癌症类型、阶段、年龄组、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
产品类型
- 仪器
- 耗材及配件
根据产品类型，北美喉癌诊断市场分为仪器和消耗品及配件。
测试类型
- 影像检查
- 验血
- 活检
- 其他的
根据测试类型，北美喉癌诊断市场分为影像测试、血液测试、活检和其他。
癌症类型
- 咽癌
- 喉癌
根据癌症类型，北美喉癌诊断市场分为咽癌和喉癌。
阶段
- 第 0 阶段
- 第一阶段
- 第二阶段
- 第三阶段
- 第四阶段
根据分期，北美喉癌诊断市场分为 0 期、I 期、II 期、III 期和 IV 期。
年龄组
- 30-65
- 65 岁及以上
- 21-29
- 21岁以下
On the basis of age group, the North America throat cancer diagnostics market is segmented into 30-65, 65 and above, 21-29, and below 21.
End User
- Hospitals
- Associated labs
- Independent diagnostic laboratories
- Diagnostic imaging centers
- Cancer research institutes
- Others
On the basis of end user, the North America throat cancer diagnostics market is segmented into hospitals, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others.
Distribution Channel
- Direct tender
- Retail sales
On the basis of distribution channel, the North America throat cancer diagnostics market is segmented into direct tender and retail sales.
North America Throat Cancer Diagnostics Market Regional Analysis/Insights
The North America throat cancer diagnostics market is analysed, and market size insights and trends are provided by country, product type, test type, cancer type, stages, age group, end user, and distribution channel, as referenced above.
The U.S. is expected to dominate the North America throat cancer diagnostics market due to the high prevalence of throat cancer in the region, and rapid research development is boosting the market.
The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of North America brands and their challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Throat Cancer Diagnostics Market Share Analysis
The North America throat cancer diagnostics market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company’s focus on the North America throat cancer diagnostics market.
北美喉癌诊断市场的一些主要参与者包括 F. Hoffmann-La Roche Ltd.、富士胶片株式会社、赛默飞世尔科技公司、佳能医疗系统公司、荷兰皇家飞利浦公司、默克集团、BD、通用电气公司、Illumina、安捷伦科技公司、Bio-Rad Laboratories, Inc.、雅培、QIAGEN、西门子医疗有限公司、Myriad Genetics Inc.、Quest Diagnostics Incorporated、Hologic、FONAR Corp.、Time Medical Holding.、MinFound Medical Systems Co., Ltd 和 PlexBio 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 INDUSTRY INSIGHTS
6 EPIDEMIOLOGY
7 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS
7.1 REGULATORY SCENARIO IN THE U.S
7.2 REGULATORY SCENARIO IN AUSTRALIA
7.3 REGULATORY SCENARIO IN JAPAN
7.4 REGULATORY SCENARIO IN CHINA
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 GROWING PREVALENCE OF THROAT CANCER
8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS
8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER
8.2 RESTRAINTS
8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER
8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES.
8.3 OPPORTUNITIES
8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT
8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS
8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.4 CHALLENGES
8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES
8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
9 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 INSTRUMENTS
9.2.1 PATHOLOGY-BASED INSTRUMENTS
9.2.1.1 PCR INSTRUMENTS
9.2.1.2 SLIDE STAINING SYSTEMS
9.2.1.3 TISSUE PROCESSING SYSTEMS
9.2.1.4 CELL PROCESSORS
9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS
9.2.2 IMAGING INSTRUMENTS
9.2.2.1 ULTRASOUND SYSTEMS
9.2.2.2 CT SYSTEMS
9.2.2.3 MRI SYSTEMS
9.2.2.4 OTHERS
9.2.3 BIOPSY INSTRUMENTS
9.2.4 OTHERS
9.3 CONSUMABLES & ACCESSORIES
9.3.1 KITS
9.3.1.1 PCR KITS
9.3.1.2 DNA POLYMERASE KITS
9.3.1.3 NUCLEIC ACID ISOLATION KITS
9.3.1.4 OTHERS
9.3.2 REAGENTS
9.3.2.1 ASSAYS
9.3.2.2 BUFFERS
9.3.2.3 PRIMERS
9.3.2.4 OTHERS
9.3.3 PROBES
9.3.4 OTHER CONSUMABLES
10 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE
10.1 OVERVIEW
10.2 IMAGING TEST
10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN
10.2.2 MRI
10.2.3 CHEST X-RAY
10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN
10.2.5 OTHERS
10.3 BLOOD TEST
10.3.1 BLOOD CHEMISTRY TESTS
10.3.2 COMPLETE BLOOD COUNT (CBC)
10.3.3 OTHERS
10.4 BIOPSY
10.4.1 ENDOSCOPIC BIOPSY
10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY
10.4.3 OTHERS
10.5 OTHERS
11 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
11.1 OVERVIEW
11.2 PHARYNGEAL CANCER
11.2.1 NASOPHARYNGEAL CANCER
11.2.2 OROPHARYNGEAL CANCER
11.2.3 HYPOPHARYNGEAL CANCER
11.3 LARYNGEAL CANCER
12 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES
12.1 OVERVIEW
12.2 STAGE III
12.3 STAGE II
12.4 STAGE IV
12.5 STAGE I
12.6 STAGE 0
13 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE
13.1 OVERVIEW
13.2 30-65
13.3 65 AND ABOVE
13.4 21-29
13.5 BELOW 21
14 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 ASSOCIATED LABS
14.4 INDEPENDENT DIAGNOSTIC LABORATORIES
14.5 DIAGNOSTIC IMAGING CENTERS
14.6 CANCER RESEARCH INSTITUTES
14.7 OTHERS
15 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 RETAIL SALES
16 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY REGION
16.1 NORTH AMERICA
16.1.1 U.S.
16.1.2 CANADA
16.1.3 MEXICO
17 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 F. HOFFMANN- LA ROCHE LTD
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENT
19.2 FUJIFILM CORPORATION
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENT
19.3 THERMO FISHER SCIENTIFIC INC.
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 CANON MEDICAL SYSTEMS CORPORATION
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENT
19.5 KONINKLIJKE PHILIPS N.V.
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENT
19.6 ABBOTT
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 AGILENT TECHNOLOGIES, INC.
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENT
19.8 BD
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENTS
19.9 BEIJING O&D BIOTECH CO., LTD.
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENT
19.1 BIO-RAD LABORATORIES, INC.
19.10.1 COMPANY SNAPSHOT
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENT
19.11 FONAR CORP.
19.11.1 COMPANY SNAPSHOT
19.11.2 REVENUE ANALYSIS
19.11.3 PRODUCT PORTFOLIO
19.11.4 RECENT DEVELOPMENT
19.12 GE HEALTHCARE
19.12.1 COMPANY SNAPSHOT
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENT
19.13 HOLOGIC INC.
19.13.1 COMPANY SNAPSHOT
19.13.2 REVENUE ANALYSIS
19.13.3 PRODUCT PORTFOLIO
19.13.4 RECENT DEVELOPMENT
19.14 ILLUMINA, INC.
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT DEVELOPMENT
19.15 MEDONICA CO. LTD
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
19.16 MERCK KGAA
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENT
19.17 MINFOUND MEDICAL SYSTEMS CO., LTD
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 MYRIAD GENETICS, INC.
19.18.1 COMPANY SNAPSHOT
19.18.2 REVENUE ANALYSIS
19.18.3 PRODUCT PORTFOLIO
19.18.4 RECENT DEVELOPMENT
19.19 PLEXBIO
19.19.1 COMPANY SNAPSHOT
19.19.2 PRODUCT PORTFOLIO
19.19.3 RECENT DEVELOPMENT
19.2 QIAGEN
19.20.1 COMPANY SNAPSHOT
19.20.2 REVENUE ANALYSIS
19.20.3 PRODUCT PORTFOLIO
19.20.4 RECENT DEVELOPMENT
19.21 QUEST DIAGNOSTICS INCORPORATED
19.21.1 COMPANY SNAPSHOT
19.21.2 REVENUE ANALYSIS
19.21.3 PRODUCT PORTFOLIO
19.21.4 RECENT DEVELOPMENT
19.22 SIEMENS HEALTHCARE GMBH
19.22.1 COMPANY SNAPSHOT
19.22.2 REVENUE ANALYSIS
19.22.3 PRODUCT PORTFOLIO
19.22.4 RECENT DEVELOPMENT
19.23 STERNMED GMBH
19.23.1 COMPANY SNAPSHOT
19.23.2 PRODUCT PORTFOLIO
19.23.3 RECENT DEVELOPMENT
19.24 TIME MEDICAL HOLDING.
19.24.1 COMPANY SNAPSHOT
19.24.2 PRODUCT PORTFOLIO
19.24.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA CONSUMABLES AND ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA LARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA STAGE III IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA STAGE II IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA STAGE IV IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA STAGE I IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA STAGE 0 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA 30-65 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA 65 AND ABOVE IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA 21-29 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA BELOW 21 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA HOSPITAL IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA ASSOCIATED LABS IN THROAT CANCER DIAGNOSTICS MARKET, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA INDEPENDENT DIAGNOSTIC LABORATORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA DIAGNOSTIC IMAGING CENTERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA CANCER RESEARCH INSTITUTES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA DIRECT TENDER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA RETAIL SALES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 59 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 60 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 61 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 U.S. INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 U.S. PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 U.S. IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 U.S. CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 66 U.S. KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 U.S. REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 69 U.S. IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 70 U.S. BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 71 U.S. BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 72 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 73 U.S. PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 74 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 75 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 76 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 77 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 78 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 CANADA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 CANADA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 CANADA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 CANADA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 CANADA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 CANADA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 86 CANADA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 87 CANADA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 88 CANADA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 89 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 90 CANADA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 91 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 92 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 93 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 94 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 95 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 MEXICO INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 MEXICO PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 MEXICO IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 MEXICO CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 MEXICO KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 MEXICO REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 103 MEXICO IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 104 MEXICO BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 105 MEXICO BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 106 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 107 MEXICO PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)
TABLE 108 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)
TABLE 109 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 110 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THROAT CANCER IS EXPECTED TO DRIVE THE NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE INSTRUMENT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET
FIGURE 14 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022
FIGURE 19 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022
FIGURE 23 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2022
FIGURE 27 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE
FIGURE 30 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022
FIGURE 31 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 34 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2022
FIGURE 35 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 36 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 39 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 40 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 41 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 43 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 44 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 45 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 46 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030)
FIGURE 47 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
